Anlon Healthcare (NSE:AHCL) Insider Ownership: 0.00 % (As of Sep. 06, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AHCL Anlon Healthcare Ltd NSE:AHCL
19 GF Score
Price ₹15.68
! 5 Warning Signs
View Full Analysis

What is Anlon Healthcare Insider Ownership?

Anlon Healthcare NSE:AHCL +0.51% 19 Insider Ownership is 0.00 % as of Sep. 06, 2026. GuruFocus rates NSE:AHCL with a GF Score™ of 19/100. The stock has 5 warning signs investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Anlon Healthcare's insider ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Anlon Healthcare's Institutional Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Anlon Healthcare's Float Percentage Of Total Shares Outstanding is 0.00%.

Anlon Healthcare Insider Ownership Historical Data

* Premium members only.

The historical data trend for Anlon Healthcare's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anlon Healthcare Insider Ownership Chart

Anlon Healthcare Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Insider Ownership
0.00 0.00 0.00 0.00 0.00

Anlon Healthcare Quarterly Data
Mar22 Mar23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Insider Ownership Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:AHCL
19GF Score
Anlon Healthcare Ltd NSE:AHCL
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anlon Healthcare Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 0.00 % mean?
Anlon Healthcare (NSE:AHCL) has a Insider Ownership of 0.00 % as of Sep. 06, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Anlon Healthcare and its competitors.
Is Anlon Healthcare's Insider Ownership too high?
Anlon Healthcare's current Insider Ownership is 0.00 %. Overall, Anlon Healthcare has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Anlon Healthcare's Insider Ownership compare to ZTS?
Anlon Healthcare's Insider Ownership of 0.00 % can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Drug Manufacturers company?
A good Insider Ownership depends on the Drug Manufacturers industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Anlon Healthcare and its competitors. Anlon Healthcare's current Insider Ownership is 0.00 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anlon Healthcare stock overvalued right now?
Anlon Healthcare (NSE:AHCL) has a current Insider Ownership of 0.00 %. The current Insider Ownership is 0.00 %. Anlon Healthcare's overall GF Score™ is 19/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Anlon Healthcare (NSE:AHCL), the current Insider Ownership is 0.00 % as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anlon Healthcare Business Description

Other Exchanges 544497:India
Address Kalawad Road, 101/102, Silvercoin Complex, Opposite Crystal Mall, Rajkot, GJ, IND, 360 005
Anlon Healthcare Ltd is a chemical manufacturing company engaged in manufacturing of; (i) high purity advance pharmaceutical intermediates which serves as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients; and (ii) active pharmaceutical ingredients which serves as a raw material for pharmaceutical formulations in preparation of various type of Finished Dosage Formula such as tablet, capsules, ointment, syrup etc, ingredients in nutraceuticals formulations, personal care products and animal health products. Its products spans across the family of pharmaceutical intermediates, active pharmaceutical ingredients, nutraceutical APIs and ingredients for personal care and veterinary API.
19GF Score

Get the complete analysis for NSE:AHCL

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.68
Price